This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 March 2023 and includes updates on COVID-19, iatrogenic botulism, group A streptococcal infection, influenza, chikungunya and dengue, and influenza B among young people.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 February 2023 and includes updates on the Earthquake in Türkiye and Syria, COVID-19, Influenza A (H5N1), Group A streptococcal infection, and cholera.
Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.
Chikungunya is not endemic in the EU/EEA and the majority of the cases are travellers infected outside of the EU/EEA. When the environmental conditions are favourable, in areas where Ae. albopictus is established, viraemic travel-related cases may generate a local transmission of the virus as demonstrated by the sporadic events of chikungunya virus transmission since 2007.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 23-29 January 2023 and includes updates on COVID-19, diphtheriae, influenza, chikungunya, dengue and poliomyelitis.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 15-21 January 2023 and includes updates on COVID-19, diphtheriae, influenza, Mpox and Cholera.